11.12.2024 13:32:17
|
EQS-News: SREP capital requirements for Commerzbank unchanged for 2025 – distance to MDA threshold remains comfortable
EQS-News: Commerzbank Aktiengesellschaft
/ Key word(s): Miscellaneous
In the annual Supervisory Review and Evaluation Process (SREP) the European Central Bank has determined the bank-specific capital requirements for the Commerzbank Group in 2025. The additional own funds requirement for Pillar 2 (P2R) remains unchanged at 2.25% of total capital, of which at least 1.27% must be covered with Common Equity Tier 1 (CET1) capital. The SREP decision replaces the previous SREP decision with effect from 1 January 2025. As of 30 September 2024, the pro forma CET1 requirement for the Commerzbank on Group level amounts to 10.31% of risk-weighted assets (MDA threshold) when applying the new SREP decision. The requirement consists of the CET1 minimum requirement of 4.5%, the P2R of 1.27%, the capital conservation buffer of 2.5%, the capital buffer for otherwise systemically important institutions of 1.25%, the countercyclical capital buffer of currently 0.66%, the sectoral systemic risk buffer of currently 0.1%, and an AT1 shortfall of 0.04% at that point in time. In addition, the requirement to maintain additional own funds for the leverage ratio (Pillar 2 requirement for the risk of excessive leverage – P2R-LR), which was introduced last year, remains unchanged at 0.1%. The resulting leverage ratio requirement of 3.1% is met by a leverage ratio of 4.4% as of September 2024. “With a CET1 ratio of 14.82% as of September 2024, we are well above the MDA threshold. This provides us with a comfortable buffer to continue to implement the return of capital to our shareholders – and, as planned, to increase it in the coming years,” said Commerzbank CEO Bettina Orlopp. As part of its strategic plans until 2027, Commerzbank aims for a CET1 ratio of 13.5%.
Press contact Investors’ contact
About Commerzbank Disclaimer
11.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Commerzbank Aktiengesellschaft |
Kaiserstraße 16 | |
60311 Frankfurt am Main | |
Germany | |
Phone: | +49 (069) 136 20 |
Fax: | - |
E-mail: | newsroom@commerzbank.com |
Internet: | www.commerzbank.de |
ISIN: | DE000CBK1001 |
WKN: | CBK100 |
Indices: | DAX, CDAX, HDAX, PRIMEALL |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2049117 |
End of News | EQS News Service |
|
2049117 11.12.2024 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Commerzbankmehr Nachrichten
11.12.24 |
EQS-News: SREP-Kapitalanforderungen an Commerzbank für 2025 unverändert – Abstand zur MDA-Schwelle weiter komfortabel (EQS Group) | |
11.12.24 |
EQS-News: SREP capital requirements for Commerzbank unchanged for 2025 – distance to MDA threshold remains comfortable (EQS Group) | |
10.12.24 |
Aufschläge in Frankfurt: LUS-DAX zeigt sich fester (finanzen.at) | |
10.12.24 |
Aufschläge in Frankfurt: Anleger lassen LUS-DAX am Mittag steigen (finanzen.at) | |
10.12.24 |
Angespannte Stimmung in Frankfurt: DAX fällt zurück (finanzen.at) | |
10.12.24 |
Commerzbank-Analyse: Buy-Bewertung von Warburg Research für Commerzbank-Aktie (finanzen.at) | |
10.12.24 |
Börse Frankfurt: DAX beginnt Dienstagshandel im Minus (finanzen.at) | |
10.12.24 |
Börse Frankfurt: LUS-DAX beginnt Handel mit Gewinnen (finanzen.at) |
Analysen zu Commerzbankmehr Analysen
10.12.24 | Commerzbank Buy | Warburg Research | |
06.12.24 | Commerzbank Overweight | JP Morgan Chase & Co. | |
27.11.24 | Commerzbank Sector Perform | RBC Capital Markets | |
07.11.24 | Commerzbank Buy | Deutsche Bank AG | |
07.11.24 | Commerzbank Overweight | JP Morgan Chase & Co. |